Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 10 de 10
Filter
1.
Clin Oncol (R Coll Radiol) ; 35(4): 269-277, 2023 04.
Article in English | MEDLINE | ID: mdl-36710153

ABSTRACT

AIMS: As the US population continues to age, oncological strategies and outcomes for soft tissue sarcomas (STSs) should continue to be examined for varying age groups. The aim of this study was analyse and compare treatment strategies and oncological outcomes for octogenarian patients with STSs. MATERIALS AND METHODS: Data from the Surveillance, Epidemiology and End Results (SEER) national database were used. Varying treatment modalities were studied when utilised for specific tumour staging with respect to the eighth edition of the American Joint Committee on Cancer. RESULTS: In total, 24 666 patients were included for analysis, where 3341 (14%) were 80 years old or older. The octogenarian group was diagnosed with more advanced disease (stages II-IV), relative to their younger counterparts (85% versus 75%, P < 0.001). However, a smaller proportion of the older patients underwent surgical resection (74% versus 86%, P < 0.001). Likewise, the octogenarians received less chemotherapy (4% versus 21%, P < 0.001) and radiotherapy (29% versus 42%, P = 0.010). Surgical resection and chemotherapy significantly improved overall survival for those older patients with stage II STS, whereas surgical resection and radiotherapy improved mortality in this cohort with both stage III and IV STS. Overall survival at 1 and 5 years of follow-up was lower within the octogenarian group compared with the younger group (1 year: 68% versus 88%, P < 0.001 and 5 years: 7% versus 58%, P < 0.001). CONCLUSIONS: Octogenarian patients, in most cases, are diagnosed with stage III or metastatic disease. Surgical resection of the primary tumour was beneficial in both age cohorts, with radiotherapy correlating to better overall survival when used in those patients with higher stage STS. Chemotherapy was associated with better mortality in the younger cohort with respect to tumour stage. The octogenarian overall survival at 1 and 5 years was lower than for younger patients.


Subject(s)
Sarcoma , Soft Tissue Neoplasms , Aged, 80 and over , Humans , Retrospective Studies , Octogenarians , Sarcoma/epidemiology , Sarcoma/therapy , Neoplasm Staging
2.
Musculoskelet Surg ; 106(1): 59-68, 2022 Mar.
Article in English | MEDLINE | ID: mdl-32638225

ABSTRACT

INTRODUCTION: While lung is the most common site of metastasis, bone metastasis of soft tissue sarcoma is a part of the natural history affecting the prognosis of these patients. To date, no studies have analyzed the histologic subtypes more likely to metastasize to bone, the risk factors for bone metastasis at initial presentation, or the effect that bone metastasis has on the survival of these patients. MATERIAL/METHODS: Patients were identified from the Surveillance, Epidemiology and End Results database with primary extremity STS between 2010 and 2015. Risk factors for early bone metastasis, survival based on different sites of metastasis, and prognostic factors of survival were analyzed. RESULTS: Among 8,234 STS, 2.2% (n = 180) presented with skeletal metastasis. Bone metastasis was more likely when regional lymph nodes were involved (OR = 4.48, p = 0.008). Deep and moderate or high-grade sarcomas had 5-12-fold tendency to present with bone and lung metastasis (p = 0.046, 0.006, 0.030, respectively). The 5-year survival rate was 41.2% (26.9-54.9%) for isolated bone metastasis and 32.9% (21.2-45.1%) for patients with bone and lung metastasis. Resection of the primary sarcoma was the only significant predictor of survival (HR = 0.44, p = 0.021) for patients with bone metastasis. CONCLUSION: High tumor grade, deep location to fascia and regional lymph node metastasis are significant risk factors for skeletal metastasis at diagnosis of an extremity STS. While neither systemic chemotherapy nor radiotherapy of the primary sarcoma has a significant influence on survival in the presence of bone metastasis, radical resection of the primary STS is associated with increased survival.


Subject(s)
Sarcoma , Soft Tissue Neoplasms , Extremities/pathology , Humans , Prognosis , Registries , Retrospective Studies , Risk Factors , Sarcoma/drug therapy , Soft Tissue Neoplasms/pathology , Survival Analysis
3.
Musculoskelet Surg ; 106(1): 35-41, 2022 Mar.
Article in English | MEDLINE | ID: mdl-32451845

ABSTRACT

PURPOSE: To compare reamed intramedullary nailing (RIM) versus un-reamed intramedullary nailing (URIM) for the treatment of impending and pathological fractures of the humeral shaft in terms of 24-h postoperative pain, blood transfusion requirements, surgical time, surgical complications, medical complications, length of stay and consolidation rates. METHODS: A retrospective comparative study between January 2013 and December 2018 was conducted. Student's t test, Mann-Whitney U and Chi-square tests were used to detect differences within the two study groups. Multiple linear regression was done to adjust for possible confounders. RESULTS: A total of 53 patients (33 RIM vs. 20 URIM) underwent humeral nailing. Fifteen (28%) were impending fractures (7 RIM vs. 8 URIM). Multiple myeloma (49%) and metastatic carcinoma (39.6%) were the most common etiologies. Pain score (5.13 ± 0.68 RIM vs. 6.78 ± 0.62 URIM; p = 0.082) and total dose of opioids (33.125 ± 27.6 RIM vs. 33.3 ± 22.28 URIM; p = 0.462) showed similar results. Blood transfusion was more prevalent within RIM group (34.48% RIM vs. 20% URIM; p = 0.044) with a clinical tendency of higher blood loss (207.86 ± 150.83RIM vs. 127.00 ± 179.98 URIM; p = 0.092). There was a consolidation rate of 71.05% (27/38) with no statistical difference (73.08% (19/26) RIM vs. 66.67% (8/12) URIM; p = 0.685). CONCLUSION: Our study suggests possible benefit of URIM in terms of less blood transfusions with no difference in consolidation rates. Even though without significance, a tendency to less blood loss, less events of systemic complication and lower length of stay was observed with URIM. Despite its limitations, this study can be used to design future prospective ventures that quantify patient-reported outcomes and provide more clear evidence.


Subject(s)
Fracture Fixation, Intramedullary , Fractures, Spontaneous , Humeral Fractures , Bone Nails , Diaphyses , Humans , Humeral Fractures/surgery , Humerus/surgery , Retrospective Studies , Treatment Outcome
5.
Musculoskelet Surg ; 102(3): 213-221, 2018 Dec.
Article in English | MEDLINE | ID: mdl-29392614

ABSTRACT

A systematic review of the cases documented in the literature regarding Pleomorphic hyalinizing angiectatic tumor of soft parts (PHAT) was performed in order to identify (1) location on presentation (2) surgical treatment modality (3) recurrence rate (4) any associations between location, age, histology, surgery type on recurrence. A systematic review of medical literature listed on PubMed was conducted identifying any prior case report and/or case series of diagnosed PHAT, with no exclusion based on language or time. Twenty-nine articles were identified removing any articles with duplicated cases yielding a total of 93 cases. Cases were broken down by gender, presenting location (UE/LE/axial), surgery type [wide local resection, non-wide local, wide local with radiation therapy (RT), non-wide local with RT], recurrence, and time to recurrence. The mean age at presentation was 54.5 ± 17.1 (range 10-89) with the 76% of cases appearing in the lower extremity (15% UE, 9% Axial). Of the 93 patients, 74 had a known surgical procedure, 31% WL, 40% NWL, 8% WL + RT, 1% NWL + RT. Of those treated surgically, 63 pts had documented follow-up and 18 (29%) had recurrence. A strong association was observed between surgery type and recurrence. Local recurrence was more common within the group undergoing NWLE in 52% (16/41) of cases (p = 0.002). Kaplan-Meier analysis showed an estimate mean time for recurrence of 43.87 months [95% confidence interval (CI) 24.52-63.22; and standard error (SE) 7.59] for the entire population. A trend was also seen toward males having a shorter disease-free survival than females (29.4 mos. vs. 69.5 mos.). No significant association seen between size, location, histology type and recurrence. PHAT has a characteristic presentation in the LE with a relatively high rate of local recurrence and slow-growing potential. Wide local excision appears to be superior in decreasing recurrence rates and a long-term follow-up period is needed.


Subject(s)
Soft Tissue Neoplasms/therapy , Age Distribution , Combined Modality Therapy , Disease Management , Disease-Free Survival , Follow-Up Studies , Humans , Neoplasm Recurrence, Local , Sex Distribution , Soft Tissue Neoplasms/epidemiology , Soft Tissue Neoplasms/radiotherapy , Soft Tissue Neoplasms/surgery , Treatment Outcome
6.
Musculoskelet Surg ; 102(2): 95-109, 2018 Aug.
Article in English | MEDLINE | ID: mdl-28986742

ABSTRACT

The need for wide local excision (WLE) versus intralesional (IL) treatment of low-grade chondrosarcomas (CS) of the appendicular skeleton remains controversial. We sought to perform a systematic review and meta-analysis to compare different conventional types of surgical treatments for grade I CS in terms of: (1) rate of local recurrence (LR) and metastases, (2) functional outcome as measured by the Musculoskeletal Tumor Society (MSTS) score, (3) complication rate. Eighteen studies enrolling 695 patients met our criteria. Studies reported on WLE versus IL treatment (n = 7), and IL treatment with or without different adjuvants (N = 11). The LR rate was not significantly different between WLE and IL treatment (OR 2.31; 95% CI, 0.85-6.2; P = 0.1). On the contrary, complication rates were significantly lower in favor of IL treatment (OR 2.27; 95% CI, 0.07-0.72; P = 0.012). The mean reported MSTS score ranged from 21.8 to 28.2 for WLE and from 26.5 to 29.7 for IL treatment, with a significant difference in favor of IL treatment. IL treatment as an alternative to WLE does not greatly increase the risk of LR or metastasis and has lower complication rates with better functional scores. In light of the retrospective nature of the studies available, our findings should be interpreted with caution.


Subject(s)
Bone Neoplasms/surgery , Chondrosarcoma/surgery , Curettage/methods , Osteotomy/methods , Bone Neoplasms/therapy , Chondrosarcoma/pathology , Chondrosarcoma/therapy , Cohort Studies , Combined Modality Therapy , Cryotherapy , Curettage/statistics & numerical data , Disease-Free Survival , Femoral Neoplasms/surgery , Humans , Humerus/surgery , Kaplan-Meier Estimate , Neoplasm Grading , Neoplasm Metastasis , Neoplasm Recurrence, Local/epidemiology , Osteotomy/statistics & numerical data , Phenol/therapeutic use , Postoperative Complications/epidemiology , Reoperation/statistics & numerical data , Retrospective Studies , Risk , Tibia/surgery , Treatment Outcome
7.
Thromb Res ; 100(6): 489-94, 2000 Dec 15.
Article in English | MEDLINE | ID: mdl-11152928

ABSTRACT

Intron 40 of the human von Willebrand factor (vWF) gene contains a polymorphic region with three variable-number tandem repeats (VNTRs), type (ATCT)n. In the present report, we evaluated the allelic frequencies of these three VNTRs in a population constituted by 51 Brazilian Caucasian and 25 Types 1, 2, and 3 von Willebrand disease (vWD) patients, and performed segregation analysis in eight families affected by vWD Types 1 and 2. Three pairs of primers were used to amplify independently nucleotides 1640-1794 (VNTR 3), 1890-1991 (VNTR 1), and 2215-2396 (VNTR 2) from intron 40. The observed heterozygosities (0.86, 0.66, and 0.66 for VNTRs 3, 1, and 2, respectively) were in accordance with the expected heterozygosities derived from the allele frequencies (0.81, 0.64, and 0.70, respectively). Although the three VNTRs were highly polymorphic, VNTR 3 showed the highest values of heterozygosity [Haemostasis 25 (1995) 264; Hum. Mol. Genet. 1 (1992) 287.].


Subject(s)
Tandem Repeat Sequences/genetics , von Willebrand Diseases/classification , von Willebrand Diseases/genetics , von Willebrand Factor/genetics , Alleles , Brazil/epidemiology , Family Health , Female , Gene Frequency , Heterozygote , Humans , Introns , Male , Pedigree , Polymerase Chain Reaction , White People/genetics , von Willebrand Diseases/epidemiology
8.
Rev Esp Med Nucl ; 17(2): 89-93, 1998.
Article in Portuguese | MEDLINE | ID: mdl-9611278

ABSTRACT

To evaluate the scintigraphy images of 99mTc-tetrofosmin in the primary hyperparathyroidism, we studied 8 patients, 5 males, with ages between 17 and 82 (median = 50) years old, and with clinical and laboratory manifestations of hyperparathyroidism (calcium metabolism and PTH elevated); parathyroid scintigraphy was realized after 20mCi (740 MBq) intravenously injection of 99mTc-tetrofosmin, and were acquired images (10, 60 and 120 min.) in a large field gamma camera. All patients were submitted to surgery. The histology of surgical specimens showed seven adenomas and one adenocarcinoma of parathyroids; the scintigraphic images showed four lesions in the inferior right lobe and four in the inferior left lobe of thyroid and have global correlation with surgical findings. There was preferential retention of the tracer in the earlier images (10 min) in all cases (100%) and in the later images (120 min.) in 5 cases (62.5%). In conclusion, the earlier images (10 min) were more diagnostic than the later in the primary hyperparathyroidism study. It is possible that other tumoral lesions have similar behavior with 99mTc-tetrofosmin.


Subject(s)
Adenocarcinoma/diagnostic imaging , Adenoma/diagnostic imaging , Hyperparathyroidism/diagnostic imaging , Organophosphorus Compounds , Organotechnetium Compounds , Parathyroid Neoplasms/diagnostic imaging , Radiopharmaceuticals , Adenocarcinoma/complications , Adenocarcinoma/surgery , Adenoma/complications , Adenoma/surgery , Adolescent , Adult , Aged , Aged, 80 and over , Evaluation Studies as Topic , Female , Humans , Hyperparathyroidism/etiology , Male , Middle Aged , Parathyroid Neoplasms/complications , Parathyroid Neoplasms/surgery , Radionuclide Imaging , Time Factors
SELECTION OF CITATIONS
SEARCH DETAIL